The crucial role of the RANKL/RANK/OPG signaling pathways in regulating bone metabolism is underscored by findings that genetic mutations that activate RANK and that inhibit the RANKL binding properties of OPG are associated with familial expansile osteolysis [27] and with juvenile Paget's disease [28], respectively. This evidence concerns the gene TNFSF11 and juvenile Paget disease.